Intracellular pH plays a critical role in glucose-induced time-dependent potentiation of insulin release in rat islets.
The underlying mechanisms of glucose-induced time-dependent potentiation in the pancreatic beta-cell are unknown. It had been widely accepted that extracellular Ca(2+) is essential for this process. However, we consistently observed glucose-induced priming under stringent Ca(2+)-free conditions, provided that the experiment was conducted in a HEPES-buffered medium as opposed to the bicarbonate (HCO(3)(-))-buffered medium used in previous studies. The critical difference between these two buffering systems is that islets maintain a lower intracellular pH in the presence of HEPES. The addition of HEPES to a HCO(3)(-)-buffered medium produced a dramatic decrease in the intracellular pH. If it is the lower intracellular pH in islets in a HEPES-buffered medium that is permissive for glucose-induced time-dependent potentiation (TDP), then experimental lowering of intracellular pH by other means should allow TDP to occur in a Ca(2+)-free HCO(3)(-)-buffered medium, where TDP normally does not occur. As expected, experimental acidification produced by dimethyl amiloride (DMA) allowed glucose to induce TDP in a Ca(2+)-free HCO(3)(-)-buffered medium. DMA also enhanced the priming normally present in HEPES-buffered media. Priming was also enhanced by transient acidification caused by acetate. Experimental alkalinization inhibited the development of priming. In the presence of Ca(2+), the magnitude of glucose-induced TDP was higher in a HEPES-buffered medium than in an HCO(3)(-)-buffered medium. In summary, glucose-induced priming was consistently observed under conditions of low intracellular pH and was inhibited with increasing intracellular pH, irrespective of the presence of extracellular Ca(2+). These data indicate that glucose-induced TDP is critically dependent on intracellular pH.
Gunawardana
Subhadra C
SC
Department of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA.
Sharp
Geoffrey W G
GW
D000818:Animals; D002021:Buffers; D002118:Calcium / Q000494:pharmacology; D002478:Cells, Cultured; D003470:Culture Media; D005947:Glucose / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007424:Intracellular Fluid / Q000502:physiology*; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D051381:Rats; D017208:Rats, Wistar
D002021:Buffers; D003470:Culture Media; D007328:Insulin; D005947:Glucose; D002118:Calcium